ContraFect Corporation Announces Separation of Units Sold in IPO
09 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
03 sept. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.
02 sept. 2014 17h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option
27 août 2014 17h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 27, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Closing of Initial Public Offering
04 août 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 4, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Announces Pricing of Its Initial Public Offering
29 juil. 2014 07h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Jul 29, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research
13 mai 2014 08h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 13, 2014) - ContraFect Corporation, a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening,...
ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors
24 avr. 2014 08h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Apr 24, 2014) - ContraFect Corporation, a leader in the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant...
ContraFect Announces Management Team Changes
21 nov. 2013 15h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Nov 21, 2013) - ContraFect Corporation announced that Ms. Julia P. Gregory was appointed interim Chief Executive Officer, succeeding Dr. Robert Nowinski, the...
ContraFect Corporation to Present at 12th Annual BIO Investor Forum
01 oct. 2013 09h13 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Oct 1, 2013) - ContraFect Corporation announced that Dr. Robert Nowinski, the company's founder and chief executive officer, and Julia P. Gregory, the company's...